BanderasNews
Puerto Vallarta Weather Report
Welcome to Puerto Vallarta's liveliest website!
Contact UsSearch
Why Vallarta?Vallarta WeddingsRestaurantsWeatherPhoto GalleriesToday's EventsMaps
 NEWS/HOME
 EDITORIALS
 ENTERTAINMENT
 VALLARTA LIVING
 TRAVEL / OUTDOORS
 HEALTH / BEAUTY
 HEALTH FOR WOMEN
 HEALTH FOR MEN
 DENTAL HEALTH
 ON ADDICTION
 RESOURCES
 SPORTS
 DAZED & CONFUSED
 PHOTOGRAPHY
 CLASSIFIEDS
 READERS CORNER
 BANDERAS NEWS TEAM
Sign up NOW!

Free Newsletter!
Puerto Vallarta News NetworkHealth & Beauty | July 2005 

Mexico to Require Warning Labels
email this pageprint this pageemail usWire services


While the stickers will say the drugs can cause blindness, companies say the chances of this are minimal.
Mexico asked the manufacturers of the impotence drugs Viagra, Cialis and Levitra to include a warning label about a remote risk of blindness on Friday, the same day the Food and Drug Administration ordered warnings included on U.S. labels.

The U.S. FDA statement includes a disclaimer cautioning that it's impossible to know if the pills are to blame for a rare form of blindness.

In a press statement, The Health Secretariat announced that manufacturers of the pills "will be required to include warning labels on the package." Manufacturers said they will have 240 days to implement the measure.

"There have been very rare reports of a connection between the use of these medications and optical neuropathy," the Mexican warning states.

But the warning does note that the side effect optic neuropathy, a nerve disorder occurs only "in a very small number of cases." The agency estimated that only about 38 cases have been detected, among the estimated 30 to 40 million users of the drugs.

"There have been very rare reports of a connection between the use of these medications and optical neuropathy," the warning states.

Mony de Swaan, Pfizer Mexico's regional director of corporate affairs, said his company is proposing that the Mexican warning be altered to specify that the blindness has occurred in only about one in a million users.

At issue is sudden vision loss when blood flow to the optic nerve is blocked, a condition called non-arteritic anterior ischemic optic neuropathy.

The warning also advises doctors to suspend use of the pills in the case of sudden loss of vision.



In accordance with Title 17 U.S.C. Section 107, this material is distributed without profit to those who have expressed a prior interest in receiving
the included information for research and educational purposes • m3 © 2008 BanderasNews ® all rights reserved • carpe aestus